Abbott Laboratories (NYSE:ABT) Expands Diabetes Care with FreeStyle Libre 3 Plus Launch in Canada [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
This development, alongside other approvals and partnerships like the i-STAT TBI test and mitral valve replacement system, may have bolstered investor confidence contributing to the company's quarterly share price growth of almost 5%. However, against a backdrop of generally rising market indices, these innovations would align with broader upward trends rather than signify any drastic deviation from market dynamics. Abbott Laboratories has 1 warning sign we think you should know about. Uncover the next big thing with financially sound penny stocks that balance risk and reward. The introduction of Abbott Laboratories' FreeStyle Libre 3 Plus in Canada exemplifies its ongoing commitment to innovative healthcare solutions, which may bolster its market presence and investor sentiment. Over a five-year period ending today, Abbott's total shareholder return, including share price appreciation and dividends, reached 53.08%, indicating solid long-term performance. This positions the comp
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Balloon Catheter Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033 [Yahoo! Finance]Yahoo! Finance
- Biosensors Company Evaluation Report 2025: Continuous Glucose Monitoring Breakthroughs and Advanced Diagnostic Technologies Position Abbott, Roche and Medtronic as Leaders [Yahoo! Finance]Yahoo! Finance
- Trial Set in NEC Multidistrict Litigation Against Reckitt Benckiser's Mead Johnson Led by Levin Papantonio [Yahoo! Finance]Yahoo! Finance
- Trial Set in NEC Multidistrict Litigation Against Reckitt Benckiser’s Mead Johnson Led by Levin PapantonioBusiness Wire
- [Latest] Global Malaria Diagnostics Market Size/Share Worth USD 1.45 Billion by 2035 at a 5.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [Yahoo! Finance]Latest
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- ABT's page on the SEC website